23 AGs praise pharmacies for decision to sell abortion pills - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Regulation News
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Regulation News RSS Get our newsletter
Order Prints
February 17, 2023 Regulation News
Share
Share
Post
Email

23 AGs praise pharmacies for decision to sell abortion pills

Courier-Times, The (Roxboro, NC)

A group of 23 state attorneys general have written to CVS and Walgreen, expressing their support for the sale of two abortion pills by mail.

The drugs, mifepristone and misoprostol, require a prescription but are considered safe for performing an abortion at home. The pharmacies's decision will provide millions of people access to the critical – and at times lifesaving – reproductive care, Oregon Attorney General Ellen Rosenblum, said in a letter sent Thursday to the two pharmacy chains. She and the attorneys general of California and Washington spearheaded the effort, with attorneys general from Arizona, Colorado, Connecticut, Delaware, the District of Columbia, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New Jersey, New Mexico, New York, North Carolina, Pennsylvania, Rhode Island and Vermont signing on.

Last month, the two companies announced their decision after the Food and Drug Administration enacted a rule change that will allow retail pharmacies to dispense mifepristone to patients with a prescription. They are now available through Planned Parenthood and other providers.

Mifepristone and misoprostol are commonly used for abortions and other purposes including the treatment of miscarriages, ectopic pregnancies and gastric ulcers. The FDA has approved their use for more than 20 years.

"Mifepristone and misoprostol are safe, effective medications that are prescribed by doctors for many purposes, including abortion," Rosenblum said in a statement.

Walgreens and CVS will need to obtain a certification from the FDA first.

On another front, a closely watched federal court decision is pending in Texas, where a lawsuit seeks to overturn the FDA's approval of mifepristone. Oregon's senior U.S. Sen. Ron Wyden urged the federal agency and Biden administration to ignore an injunction that would block the drug. Wyden, a Democrat, said in a speech on the Senate floor Thursday that the potential injunction is an "affront to the Constitution and to the rule of law in the United States of America."

States have become divided over reproductive rights since the U.S. Supreme Court last year overturned Roe v. Wade – and effectively empowered legislatures to put more abortion restrictions in place.

A different group of 20 attorneys general, led by Missouri, also wrote to the pharmacy chains, warning that they will violate federal law if they dispense the medications by mail.

Besides Missouri, the other attorneys general who signed onto that letter are from Alabama, Alaska, Arkansas, Florida, Georgia, Indiana, Iowa, Kentucky, Louisiana, Mississippi, Montana, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Texas, Utah and West Virginia.

Rosenblum criticized that step – and their legal reasoning. Her group's letter said the anti-abortion coalition is misinterpreting the law – and ignoring court precedent that has found it's not a violation of the law to mail those drugs because they are approved for legal abortions.

"Attorneys general in anti-abortion states are trying to scare retail pharmacy chains away from offering these critical medications," Rosenblum said. "But in a time when reproductive health care is under attack, our group of 23 attorneys general strongly believe we should be encouraging companies and providers to offer easily accessible, safe, and confidential health care as broadly as possible."

Oregon has 79 Walgreens and 28 CVS locations.

Federal lawsuit seeks ban

The FDA's 2000 approval of mifepristone faces a challenge through a federal lawsuit in Texas. The case, filed in November by the conservative advocacy group Alliance Defending Freedom, alleges the drug has health risks for patients and should be banned.

U.S. District Court Judge Matthew Kacsmaryk, nominated to the bench by former President Donald Trump, is expected to issue a ruling on the case, which could eventually make its way to the U.S. Supreme Court.

Wyden on Thursday warned that an adverse ruling could impact access to the medication throughout the United States with an injunction.

Wyden, in his speech, urged the FDA and President Joe Biden to ignore any injunction.

"Here's what must happen if and when Judge Kacsmaryk issues his nationwide injunction halting access to mifepristone," Wyden said. "President Biden and the FDA must ignore it. Don't give in to the 'court washing.'. Protect the fundamental rights and well-being of all women in America."

Wyden added: "The FDA should go on just as it has for the last 23 years since it first approved mifepristone. The FDA needs to keep this medication on the market without interruption regardless of what the ruling says. Doctors and pharmacies should go about their jobs like nothing has changed."

To defend his stance, Wyden invoked the history of President Abraham Lincoln, who called on people to ignore the Dred Scott ruling, which held that Black people could never be U.S. Citizens with constitutional rights.

Wyden said the answer is to ignore the ruling "at least until there's a final ruling on the underlying matter by the Supreme Court."

"I don't say this lightly," Wyden said. "In fact, I've never said it before."

The post 23 AGs praise pharmacies for decision to sell abortion pills appeared first on Oregon Capital Chronicle.

Older

Feds using 'enhanced surveillance' to see what's behind the natural gas spike in California

Newer

Nevadans urged to evaluate their flood risk and explore flood insurance options amid changing weather patterns

Advisor News

  • SEC nears settlement with accused scammer Tai Lopez
  • The 3 things that shrink your Social Security income
  • Proposed legislation takes aim at Social Security shortfall
  • The overlooked retirement security risk that must be addressed
  • What advisors should know about hedge funds in retirement planning
More Advisor News

Annuity News

  • Globe Life Inc. (NYSE: GL) Highlighted for Surprising Price Action
  • Trademark Application for “EMPOWER YOUR MONEY” Filed by Empower Annuity Insurance Company of America: Empower Annuity Insurance Company of America
  • Built-in guaranteed annuities: What advisors should know
  • Malibu Life Holdings Completes Acquisition of TruSpire, Establishing Malibu USA and Accelerating Entry into the U.S. Retail Annuity Market
  • Why job boards are failing insurance agencies
More Annuity News

Health/Employee Benefits News

  • An Application for the Trademark “THE HARTFORD” Has Been Filed by Hartford Fire Insurance Company: Hartford Fire Insurance Company
  • Data on Colon Cancer Reported by Researchers at Tokyo University of Science (Association between Low-Dose Aspirin Use and Colorectal Cancer Incidence Using Japanese Large-Scale Health Insurance Claims Data): Oncology – Colon Cancer
  • Research Conducted at University of Queensland Has Provided New Information about Disability and Health (Vertical and Horizontal Equity In Support for Children With Disabilities: a Cross-sectional Analysis of Australia’s National Disability …): Health and Medicine – Disability and Health
  • Pennsylvanians are dropping health coverage through Pennie, citing higher plan costs as the number one reason
  • Public worker health plans poised for another year of premium hikes
More Health/Employee Benefits News

Life Insurance News

  • AM Best Revises Outlooks to Stable for Missouri Farm Bureau Group’s Members and Farm Bureau Life Insurance Company of Missouri
  • Globe Life Inc. (NYSE: GL) Highlighted for Surprising Price Action
  • AM Best Assigns Credit Ratings to China Ping An Insurance (Hong Kong) Company Limited
  • Reliance Matrix Expands Employee Navigator Integration with New Evidence of Insurability (EOI) API Enhancement
  • How AI is changing the insurance claims process and what it means for accident victims
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • Prosperity Life GroupSM Launches Prosperity PathWaySM Series, Bringing Greater Choice and Flexibility to Retirement Income Planning
  • Senior Market Sales® Fortifies Annuity Reach With Acquisition of Retirement Planning Firm Stratton & Company
  • RFP #T01625
  • Rockwood Programs Appoints Kerry Ladouceur as Vice President, Financial Lines
  • JP Insurance Group Launches Commercial Property & Casualty Division; Appoints Joe Webster as Managing Director
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.
Insurance News | InsuranceNewsNet